Immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is
central to long-term control of the current pandemic. Despite our rapidly advancing …

Scientists across disciplines, policymakers, and journalists have voiced frustration at the
unprecedented polarization and misinformation around coronavirus disease 2019 (COVID …

Background Increased understanding of whether individuals who have recovered from
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We …

Neutralizing antibodies elicited by prior infection or vaccination are likely to be key for future
protection of individuals and populations against SARS-CoV-2. Moreover, passively …

By the beginning of November 2020, almost 50 million cases of coronavirus disease 2019
(COVID-19) had been reported worldwide, with over 35 million people defined as recovering …

Background With the continuation of the COVID-19 pandemic, some COVID-19 patients
have become reinfected with the virus. Viral gene sequencing has found that some of these …

Background Understanding the longitudinal trajectory of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibodies is crucial for diagnosis of prior infection and …

Background There is an urgent need to better understand whether individuals who have
recovered from COVID-19 are protected from future SARS-CoV-2 infection. Methods A large …

Reports of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection have
raised important questions about the strength and durability of the immune response to …

Determinants of protective immunity against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection require the development of well-standardized, reproducible …